ArticleEcancermedicalscience2021

Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer.

Adriana Regina Gonçalves Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.